Proteomics: Technologies and Global Markets

The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.

Report Includes

• An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
• Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
• Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
• Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.

The global proteomic market was worth nearly $3.7 billion in 2011 and nearly $4.2 billion in 2012, and is forecast to grow at a compound annual growth rate (CAGR) of 16.1% during the next five years to reach nearly $8.9 billion in 2017.

Report Includes

• An overview of the global proteomics market, which covers: technologies, database and software markets, equipment markets, application markets and service markets.
• Analyses of global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
• Discussion of trends and opportunities, top-selling products, key players, and a competitive outlook.
• Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.

• The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%.
• Proteomics equipment was valued at $4.1 billion in 2008 and an estimated $4.8 billion in 2009. This is expected to increase to $13.0 billion in 2014, for a CAGR of 22%..
• Proteomics technologies were worth $1.3 billion in 2008 and an estimated $1.5 billion in 2009. This segment is expected to increase at a CAGR of 13.9% to reach $2.9 billion in 2014.

• Proteomics is an emerging field that has developed in the wake of genomics. Its goal is to understand protein expression at the cellular level, and apply this information to scientific and medical problems. For example, compared to healthy cells, how does influenza virus infection affect the total protein output? Are any of the proteins expressed only in the infected cells suitable targets for new antiviral drugs? This approach also applies to cancerous cells, and cells from patients with degenerative diseases and many other conditions. New technologies like protein chips and capillary electrophoresis are emerging to serve proteomic studies, and more mature technologies like 2-D electrophoresis, mass spectroscopy, and nuclear magnetic resonance spectroscopy are being adapted for protein studies, and in some cases, for high throughput uses. Bioinformatics applications are constantly being developed to analyze the data produced by all of these technologies.
• This BCC study examines how proteomics technologies have affected basic research and pharmaceutical research, and how they are likely to affect research in the near future. It also analyzes how proteomics technologies are developing, and examines new companies that are likely to make substantial contributions to the field. An important part of the report analyzes instruments that are vital to proteomics studies. Sales and spending projections through 2006 are included.